Free Trial

Akoya Biosciences (AKYA) Competitors

Akoya Biosciences logo
$1.32 +0.02 (+1.54%)
Closing price 07/1/2025 04:00 PM Eastern
Extended Trading
$1.28 -0.04 (-3.03%)
As of 09:17 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AKYA vs. QTRX, FEIM, RPID, SEER, OWLT, PRE, KEQU, NAUT, INTT, and ODYS

Should you be buying Akoya Biosciences stock or one of its competitors? The main competitors of Akoya Biosciences include Quanterix (QTRX), Frequency Electronics (FEIM), Rapid Micro Biosystems (RPID), Seer (SEER), Owlet (OWLT), Prenetics Global (PRE), Kewaunee Scientific (KEQU), Nautilus Biotechnology (NAUT), inTEST (INTT), and Odysight.ai (ODYS). These companies are all part of the "measuring and control equipment" industry.

Akoya Biosciences vs. Its Competitors

Akoya Biosciences (NASDAQ:AKYA) and Quanterix (NASDAQ:QTRX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment.

Akoya Biosciences presently has a consensus target price of $2.51, suggesting a potential upside of 89.85%. Quanterix has a consensus target price of $15.60, suggesting a potential upside of 133.18%. Given Quanterix's stronger consensus rating and higher possible upside, analysts plainly believe Quanterix is more favorable than Akoya Biosciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Akoya Biosciences
0 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Quanterix
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Quanterix has higher revenue and earnings than Akoya Biosciences. Quanterix is trading at a lower price-to-earnings ratio than Akoya Biosciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Akoya Biosciences$81.67M0.81-$55.37M-$0.97-1.36
Quanterix$137.42M2.43-$38.53M-$1.30-5.15

Akoya Biosciences has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Comparatively, Quanterix has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.

Quanterix has a net margin of -36.82% compared to Akoya Biosciences' net margin of -59.44%. Quanterix's return on equity of -15.07% beat Akoya Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Akoya Biosciences-59.44% -487.85% -35.86%
Quanterix -36.82%-15.07%-12.26%

In the previous week, Akoya Biosciences had 2 more articles in the media than Quanterix. MarketBeat recorded 3 mentions for Akoya Biosciences and 1 mentions for Quanterix. Quanterix's average media sentiment score of 1.87 beat Akoya Biosciences' score of 0.63 indicating that Quanterix is being referred to more favorably in the news media.

Company Overall Sentiment
Akoya Biosciences Positive
Quanterix Very Positive

79.4% of Akoya Biosciences shares are owned by institutional investors. Comparatively, 86.5% of Quanterix shares are owned by institutional investors. 7.3% of Akoya Biosciences shares are owned by company insiders. Comparatively, 6.9% of Quanterix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Quanterix beats Akoya Biosciences on 11 of the 16 factors compared between the two stocks.

Get Akoya Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for AKYA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AKYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AKYA vs. The Competition

MetricAkoya BiosciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$64.94M$2.85B$5.48B$8.94B
Dividend YieldN/A2.69%5.38%4.12%
P/E Ratio-1.3621.1726.2219.74
Price / Sales0.81262.85394.92109.12
Price / CashN/A41.8936.4957.06
Price / Book8.807.237.915.37
Net Income-$55.37M-$55.05M$3.15B$248.34M
7 Day Performance3.13%-0.60%0.75%1.67%
1 Month Performance5.60%3.77%3.46%4.56%
1 Year Performance-39.45%2.20%34.60%18.42%

Akoya Biosciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AKYA
Akoya Biosciences
2.1613 of 5 stars
$1.32
+1.5%
$2.51
+89.8%
-40.3%$64.94M$81.67M-1.3690
QTRX
Quanterix
2.8346 of 5 stars
$6.30
+2.9%
$15.60
+147.6%
-47.2%$237.64M$137.42M-4.85460
FEIM
Frequency Electronics
2.4702 of 5 stars
$23.24
+9.5%
N/A+129.8%$205.34M$55.27M9.64200High Trading Volume
RPID
Rapid Micro Biosystems
2.1897 of 5 stars
$3.17
-4.5%
$8.00
+152.4%
+413.2%$145.52M$28.05M-3.08200
SEER
Seer
2.0871 of 5 stars
$1.97
-2.0%
$3.00
+52.3%
+29.6%$118.33M$14.17M-1.40160
OWLT
Owlet
0.7334 of 5 stars
$7.40
+4.6%
$7.75
+4.8%
+96.5%$116.83M$78.10M-5.17106
PRE
Prenetics Global
1.1634 of 5 stars
$8.13
-9.3%
$9.00
+10.7%
+50.5%$109.36M$30.62M-2.041Gap Down
High Trading Volume
KEQU
Kewaunee Scientific
2.3747 of 5 stars
$36.91
+0.6%
N/A+35.0%$104.73M$203.76M6.251,006Earnings Report
NAUT
Nautilus Biotechnology
2.4584 of 5 stars
$0.70
-2.7%
$2.13
+205.7%
-67.8%$90.16MN/A-1.29130Positive News
High Trading Volume
INTT
inTEST
3.4906 of 5 stars
$6.92
+0.4%
$12.00
+73.4%
-30.7%$86.47M$127.50M30.09320Positive News
ODYS
Odysight.ai
1.8116 of 5 stars
$4.82
-1.8%
$10.00
+107.5%
N/A$80.11M$3.96M-4.7340News Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:AKYA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners